Unlocking a Peptide-Based Platform for Targeted Delivery of Therapeutic Agents

• Rationally designing and optimizing AI-driven peptide-vectors for targeted delivery of different payloads including peptide, protein and RNA
• Demonstrating safety and characterization of peptide-based nanoparticles for extrahepatic delivery of RNA
• Leveraging a peptide-based nanoparticle platform for systemic targeted delivery of therapeutic mRNA: T cell engineering and tumor selectivity

NEW COMPANY

Speakers:

GIIL Divita

Chief Executive Officer

Aanastra Inc